|
1）Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010; 15: 1-20
|
|
|
|
2）Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-5
|
|
|
|
|
|
3）Asaka M, Sugiyama T, Nobuta A, et al. Atrophic gastritis and intestinal metaplasia in Japan: Results of a large multicenter study. Helicobacter. 2001; 6: 294-9
|
|
|
|
|
4）Asaka M. A new approach for elimination of gastric cancer in Japan. Int J Cancer. 2013; 132: 1272-6
|
|
|
|
|
|
5）Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345: 784-9
|
|
|
|
|
|
6）de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008; 134: 945-52
|
|
|
|
|
|
7）Arima N, Adachi K, Katsube T, et al. Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment. J Clin Gastroenterol. 1999; 29: 44-7
|
|
|
|
|
|
8）Nasu J, Doi T, Endo H, et al. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy. 2005; 37: 990-3
|
|
|
|
|
|
9）Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008; 372: 392-7
|
|
|
|
|
|
10）Makuuchi M, Kokudo N, Arii S, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008; 38: 37-51
|
|
|
|
|
11）Trends in site-specific crude mortality rate 1965-2010, Cancer Statistics in Japan-2011. 2011. p.26
|
|
|
|
|